Bloomage BioTechnology Corporation Limited (688363.SS)
CNY 48.84
(0.93%)
CNY 48.84
(0.93%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 708.38 Million CNY | -50.01% |
| 2022 | 1.13 Billion CNY | 25.48% |
| 2021 | 905.55 Million CNY | 19.62% |
| 2020 | 757.04 Million CNY | 8.21% |
| 2019 | 699.57 Million CNY | 33.39% |
| 2018 | 524.44 Million CNY | 84.47% |
| 2017 | 284.29 Million CNY | -11.28% |
| 2016 | 320.46 Million CNY | 34.5% |
| 2015 | 238.25 Million CNY | 18.18% |
| 2014 | 201.61 Million CNY | 53.28% |
| 2013 | 131.53 Million CNY | 12.19% |
| 2012 | 117.23 Million CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| 2010 | - CNY | 0.0% |
| 2009 | - CNY | 0.0% |
| 2008 | - CNY | 0.0% |
| 2007 | - CNY | 0.0% |
| 2006 | - CNY | 0.0% |
| 2005 | - CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 19.84 Million CNY | -79.67% |
| 2024 Q2 | 97.61 Million CNY | -65.51% |
| 2024 Q1 | 283.03 Million CNY | 357.27% |
| 2023 FY | 568.04 Million CNY | -50.01% |
| 2023 Q2 | 274.49 Million CNY | 12.91% |
| 2023 Q1 | 243.11 Million CNY | -22.52% |
| 2023 Q3 | 93.55 Million CNY | -65.92% |
| 2023 Q4 | 61.89 Million CNY | -33.84% |
| 2022 Q2 | 338.1 Million CNY | 39.75% |
| 2022 Q4 | 313.77 Million CNY | 29.39% |
| 2022 FY | 1.13 Billion CNY | 25.48% |
| 2022 Q3 | 242.49 Million CNY | -28.28% |
| 2022 Q1 | 241.93 Million CNY | -6.3% |
| 2021 Q3 | 228.48 Million CNY | -0.71% |
| 2021 FY | 905.55 Million CNY | 19.62% |
| 2021 Q1 | 188.74 Million CNY | -20.56% |
| 2021 Q2 | 230.12 Million CNY | 21.92% |
| 2021 Q4 | 258.2 Million CNY | 13.01% |
| 2020 Q3 | 207.48 Million CNY | 11.82% |
| 2020 Q1 | 126.41 Million CNY | -37.45% |
| 2020 Q2 | 185.54 Million CNY | 46.78% |
| 2020 FY | 757.04 Million CNY | 8.21% |
| 2020 Q4 | 237.6 Million CNY | 14.52% |
| 2019 Q1 | 130.32 Million CNY | -2.75% |
| 2019 Q3 | 175.98 Million CNY | -7.94% |
| 2019 FY | 699.57 Million CNY | 33.39% |
| 2019 Q4 | 202.1 Million CNY | 14.84% |
| 2019 Q2 | 191.16 Million CNY | 46.68% |
| 2018 FY | 524.44 Million CNY | 84.47% |
| 2018 Q4 | 134 Million CNY | -11.7% |
| 2018 Q3 | 151.75 Million CNY | 12.29% |
| 2018 Q2 | 135.14 Million CNY | 21.9% |
| 2018 Q1 | 110.86 Million CNY | 0.0% |
| 2017 Q2 | 54.3 Million CNY | 0.0% |
| 2017 Q1 | 54.3 Million CNY | -31.78% |
| 2017 FY | 284.29 Million CNY | -11.28% |
| 2016 Q4 | 79.6 Million CNY | 0.0% |
| 2016 Q2 | 69.92 Million CNY | 0.0% |
| 2016 FY | 320.46 Million CNY | 34.5% |
| 2016 Q3 | 79.6 Million CNY | 13.84% |
| 2016 Q1 | 69.92 Million CNY | 17.97% |
| 2015 Q4 | 59.27 Million CNY | 0.0% |
| 2015 FY | 238.25 Million CNY | 18.18% |
| 2015 Q3 | 59.27 Million CNY | -7.68% |
| 2015 Q2 | 64.2 Million CNY | 0.0% |
| 2015 Q1 | 64.2 Million CNY | 34.29% |
| 2014 Q1 | 52.99 Million CNY | 176.53% |
| 2014 Q3 | 47.8 Million CNY | -9.79% |
| 2014 FY | 201.61 Million CNY | 53.28% |
| 2014 Q4 | 47.8 Million CNY | 0.0% |
| 2014 Q2 | 52.99 Million CNY | 0.0% |
| 2013 Q2 | 46.6 Million CNY | 0.0% |
| 2013 Q3 | 19.16 Million CNY | -58.87% |
| 2013 Q4 | 19.16 Million CNY | 0.0% |
| 2013 FY | 131.53 Million CNY | 12.19% |
| 2013 Q1 | 46.6 Million CNY | 101.01% |
| 2012 FY | 117.23 Million CNY | 0.0% |
| 2012 Q4 | 23.18 Million CNY | 0.0% |
| 2012 Q3 | 23.18 Million CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |
| 2010 FY | - CNY | 0.0% |
| 2009 FY | - CNY | 0.0% |
| 2008 FY | - CNY | 0.0% |
| 2007 FY | - CNY | 0.0% |
| 2006 FY | - CNY | 0.0% |
| 2005 FY | - CNY | 0.0% |